CMS Aims To Curb Spread Pricing By Enforcing Medicaid MLR rules

By John Wilkerson / May 16, 2019 at 10:50 AM
CMS hopes to curb drug spread-pricing in Medicaid by explaining to insurers the rules for reporting health care costs. The agency worries that some insurers are claiming inflated pharmacy benefit manager drug charges as true health care costs. Spread pricing is the PBM practice of charging Medicaid managed care plans more for drugs than they pay pharmacies, then pocketing the difference. Studies of Medicaid managed care programs in Ohio , Michigan , Kentucky , and New York , plus a...


Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.